Management of functional constipation in children and adults

Mana H Vriesman1, Ilan J N Koppen2, Michael Camilleri3

  • 1Department of Pediatric Gastroenterology and Nutrition, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands. m.h.vriesman@amc.nl.

Insights

Functional constipation affects children and adults globally, presenting unique challenges in diagnosis and treatment. Management strategies differ between age groups, with intractable cases requiring specialized interventions.

Area of Science:

  • Gastroenterology
  • Pediatrics
  • Internal Medicine

Background:

  • Functional constipation is a prevalent global condition affecting both children and adults.
  • While sharing similarities, significant differences exist in epidemiology, symptoms, pathophysiology, diagnosis, and treatment between pediatric and adult populations.
  • Understanding these distinctions is crucial for effective management.

Purpose of the Study:

  • To highlight the similarities and differences in functional constipation between children and adults.
  • To outline current diagnostic and therapeutic approaches for functional constipation in both age groups.
  • To discuss management strategies for intractable functional constipation and emerging treatments.

Main Methods:

  • Review of epidemiological, symptomatic, pathophysiological, diagnostic, and therapeutic aspects of functional constipation in children and adults.
  • Comparison of management strategies, including behavioral interventions, pharmacological therapy, and surgical options.
  • Exploration of treatments for intractable functional constipation and novel therapeutic agents.

Main Results:

  • Pediatric management emphasizes behavioral aspects like toilet training and laxatives.
  • Adult management involves excluding secondary causes and differentiating subtypes (normal transit, slow transit, evacuation disorder).
  • Intractable cases in both groups may necessitate advanced interventions, including surgery, with new drugs and surgical strategies showing promise.

Conclusions:

  • Functional constipation requires tailored approaches based on age and subtype.
  • Effective management of intractable functional constipation may involve stepwise interventions, including novel pharmacological and surgical options.
  • Further research into new treatments could significantly improve outcomes for children and adults with severe functional constipation.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
654
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
603
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
498
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
961
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
580
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
411